Somatus operates a value-based kidney care model that combines proprietary technology, multi-disciplinary community-based care teams, and partnerships with nephrologists and primary care physicians to prevent disease progression and improve outcomes. The company delivers personalized, in-home care and support and focuses on prevention, awareness, increasing home dialysis use, and raising transplantation rates. Somatus has expanded rapidly, launching six new health plan partners in 2021, growing membership and reach, and adding more than 1,000 team members to exceed 1,350 total teammates. In 2022 the company will serve over 150,000 members across 34 states, spanning Medicare, Medicare Advantage, Medicaid, and Commercial plans. The model emphasizes lowering total cost of care through integrated, evidence-based interventions. Somatus is using recent funding to further expand its proven care model and build a nationwide network of providers and connected patients. Somatus delivers integrated, value-based kidney care using a vertically integrated clinical services model and a proprietary RenalIQ technology platform that powers field-based care teams. The company combines multiple data sets to predict undiagnosed disease, disease progression, utilization, and the likelihood of unplanned dialysis starts, and pairs that intelligence with specialized renal clinicians and community-based team members. Somatus reports serving more than 20,000 chronic kidney disease and end-stage kidney disease patients across six states and employs roughly a 300-person team. The model emphasizes evidence-based care pathways, personalized outreach, higher use of home dialysis modalities, and increased rates of kidney transplantation, and has produced quality and cost outcomes for partners. Somatus plans to scale its model nationally, expand partnerships with health plans, invest in technology and product development, and grow its workforce. The company will also release a patient-facing mobile application to help patients monitor kidney health goals, connect virtually with care teams, access micro-learning modules, and track transplant journeys. Somatus delivers longitudinal dialysis and care management services to patients on behalf of health system and payer customers. The company partners with enterprise customers to design population health strategies that mobilize disparate community-based care teams, prioritize lower-cost home-based therapies, and manage total cost of care for kidney populations. It operates a technology and service platform that supports those services. Somatus intends to use the Series B proceeds to extend the capabilities of its technology and service platform and to fund expansion into additional markets. Founded in 2016 and based in Vienna, Va., the company was co-founded by Dr. Ikenna Okezie (CEO) and Tony Welters (Chairman); Dr. Ramon Mendez serves as VP Medical Affairs. The company contracts with health systems and payers to deliver and manage kidney care.

Total raised

$400M

Funding rounds

3

Latest round

Series E

Latest activity

Feb 2022